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1. Introduction 
To enlighten the mechanism of enzyme action it is 
important to know the amino acids involved in catal- 
ysis. The amino acid specific reagents also attack 
amino acids outside of the active center. Therefore it 
is necessary to synthesize active site specific com- 
pounds, which are able to react here, forming a co- 
valent bond. Woenckhaus and co-workers have de- 
scribed some highly specific inactivators for NAD-de- 
pendent dehydrogenases [1-4]. An analoge of 5'AMP, 
reacting specifically with SH-groups opposite the 6- 
position of the purine part, has been synthesized by 
Fasold and Hulla [5]. 
All these nudeotide analogs are only able to modi- 
fy the binding site for the heterocyclic moieties. We 
have tried to synthesize an inactivator modifying the 
pyrophosphate or triphosphate binding sites in en- 
zymes. In this part of the enzyme there is supposed 
to be a positive charged area to which the negative 
charged phosphate residue is fixed. Therefore the in- 
activator should also contain a negative charge in 
about the same distance to the sugar part as in ADP 
or ATP. 
We have synthesized the adenosine-5'-ester of male- 
ic acid, which is converted into the ester of dibromo- 
succinic acid by addition of bromine. This a-bromo- 
carbonylic acid derivative is able to modify amino 
acid residues in the active center of NAD-dependent 
dehydrogenases and adenine nucleotide-dependent 
kinases. 
2. Experimental 
2.1. Synthesis 
2'3' Isopropylidene-adenosine (I), 10 mmole, and 
50 mmole maleic anhydride were dissolved in 500 ml 
of dry dioxane and 1 ml of pyridine was added. The 
mixture was allowed to stand in the dark at room tem- 
perature for 4 days. The solvent was removed under 
reduced pressure at 30°C. The remainder, containing 
no more 2'3'isopropylidene-adenosine when tested by 
high voltage lectrophoresis, was dissolved in 30 ml of 
water by adding some ammonia nd applied to an 
Amberlite CG50I (t-I + form) column (4 × 50 cm). The 
column was washed with water 180 ml/hr 2'3'isopropyl- 
idene-adenosine-5'hydrogen maleate (II) appeared after 
about 3.6 ~ in 5.5 £ solution. The solution was brought 
to pH 6 with 2 N NH4OH and evaporated. By addition 
of isopropyl alcohol and ether a light yellow product 
precipitated. The purity of this product was checked 
by paper electrophoresis and thin-layer chromatogra- 
phy on cellulose covered sheets (solvent, isopropyl 
alcohol: 33% ammonia: water = 7:1:3 v/v). There 
was no impurity to detect. 
To remove the protecting roup 1.3 g of l I  were 
dissolved in 10 ml of 1 N H2SO 4. The solution was 
kept in a water bath of 60°C for 10 min. The solution 
was chilled in ice and the pH adjusted to 4.5 with 
Ba(OH)2. BaSO 4 was filtered of, washed with water 
and the filtrate applied to a Ambeflite CG501 (H ÷ form) 
column (2 × 50 cm). The column was washed with 
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water. Adenosine-5'hydrogen maleate (III) was eluted 
after 600 ml in 1.8 £ solution. The fraction was lyophil- 
ized. The yield was 27%. III gave a single spot on thin- 
layer chromatography and on paper electrophoresis at 
pH 4.5. 
C14H15N507 (mol.wt. 365.30) 
calculated 46.03 C 4.14H 19.17N 
found 45.87 C 4.29H 19.03N 
Adenosine- 5'(2,3- dibormohydrogensuccinate) (IV). 
Freshly prepared III (50 mg) was dissolved in 1 ml of 
water and after addition of bromine (0.15 mmoles) 
the solution was allowed to stand in the dark. The 
solution decolorized within about 6 hr. The solution 
was extracted with 5 X 10 ml of ether to remove HBr. 
By addition of acetone IV could be precipitated. IV
Gave a single spot on paper electrophoresis at pH 4.5. 
2.2. Materials and methods 
AMP, ADP, ATP, glycerate-3-phosphate, NAD, 
NADH and phosphoenol pyruvate were obtained from 
Boehringer and Soehne, Mannheim, as were ADHyeast , 
GAPDH from rabbit muscle and 3-phosphoglycerate 
kinase. The other enzymes were prepared in our labo- 
ratory with the indicated specific activities: ADH from 
horse liver 2.5 U/mg, pyruvate kinase from pig heart 
290 U/mg, myokinase from pig heart 480 U/rag, L~H 
from pig heart 480 U/mg, cytoplasmic MDH from pig 
heart 710 U/mg and mitochondrial MDH from pig 
heart 1180 U/mg. The protein concentrations were 
quantitated using the biuret method. The enzyme ac- 
tivities were assayed at 25°C by measuring for ADH 
th~ oxidation of alcohol [6], for LDH the reduction 
of pyruvate [7] and for MDH the reduction of oxalo- 
acetate [8]. GAPDH activity was determined by the 
method of B0cher with 3,phosphoglycerate kinase [7]. 
Pyruvate kinase activity was measured in the coupled 
test with LDH (10 U/ml)in triethanolamine buffer 
pH 7.6 containing 10 mM Mg 2÷, 20 mM K +, 1.5 mM 
ADP, 0.7 mM phosphoenolpymvate nd0.2 mM 
NADH. Myokinase activity was assayed by coupling 
the pyruvate kinase reaction and the LDH reaction. 
The assay mixture contained 0.1 M triethanolamine 
buffer pH 7.6, 1.4 mM Mg 2÷, 84 mM K ÷, 2 mM AMP, 
1 mM ATP, 0.4 mM phosphoenolpyruvate, 0.2 mM 
NADH, pyruvate kinase 10 U/ml and LDH 10 U/ml. 
The inhibitor constants of adenosine-5' hydrogen- 
maleate were determined from Lineweaver and Burk 
plots. The inactivation reactions were accomplished 
at 37°C. Previous to inactivation, the enzymes were 
dialysed against he following buffers, dehydrogenases 
agains 0.5 M phosphate buffer pH 7.0, pyruvate kinase 
and myokinase against 0.1 M triethanolamine buffer 
pH 7.6 containing K + and Mg 2+ in the same concen- 
trations as in the appropriate t st mixtures. The inac- 
tivator was added in aqueous olution, the same 
amount of water was added to a blank. The decrease 
of activity was measured against he blank. 
3. Results and discussion 
Reaction of 2'3'-isopropylidene-adenosine with 
maleic anhydride yields 2'3'-isopropylidene-adenosine- 
5'-hydrogenmaleate (scheme). 
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The protecting roup can be removed by treatment 
with 1 N mineral acid liberating adenosine-5'-hydro- 
gen maleate (III). In 2 N NaOH III is split into adeno- 
sine and maleic acid. III Is a competitive inhibitor 
against ADP in the pyruvate kinase system with a 
K I = 3 X 10 -2 M, against AMP in the myokinase sys- 
tem with aK I = 1.5 X 10-2M andin the GAPDH 
catalysed reaction against NAD with aK I = 2.2 × 10 -3 
M (fig. 1). 
Bromine in aqueous olution is added to the double 
bond of the acid residue, forming the ester of dibromo- 
succinic acid (IV). Under the conditions used there is 
no 8-bromoadenosine derivative formed. Adenosine is 
brominated under the same conditions only within 14 
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Fig. 1. Lineweaver and Burk plots for the action of: a) pyruvate 
kinase, III = 10 -2 M, ADP varied 1-20 × 10 --4 M; b) myokinase, 
III = 10 -2 M, AMP varied 1-21 × 10 -4 M; c) GAPDH, III = 
1.2 × 10- 3 M, NAD varied 0.4-8 X 10 -4 M in presence 
(o - -o - -o)  and absence (o - -o - -o)  of III. 
days. Thereby the maximum of ultraviolet absorption 
is shifted 5 nm or red [9]. Such a shift does not appear 
during bromination of III. At pH 7.0 IV is stable at 
37°C, above pH 7.5 hydrolytic decomposition occurs, 
at pH 8.0 the half-life is 2.5 hr. 
In the presence of IV ADHyeast , GAPDH, myo- 
kinase and pyruvate kinase lose their enzymatic activ- 
ities (fig. 2). The fact that III is a competitive inhibitor 
for those enzymes which are inactivated by IV induced 
us to assume, that IV also attacks at the active site. 
This assumption is confirmed by the protection of 
natural substrates against inactivation. GAPDH is pro- 
tected by NAD, myokinase by AMP and ATP. Pyruvate 
kinase is little protected by ADP whereas there is no 
protection by 10 mM ATP or phosphoenolpyruvate. 
An exception is ADHyeast which is not protected by 
NAD. ADH from liver, LDH and both forms of MDH 
are not inactivated by IV. In short the synthesized 
adenosine-5'-(2,3-dibromohydrogensuccinate) is an 
active site directed inactNator of some adenine nucle- 
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Fig. 2. Semi logarithmic plots of the decrease of enzymatic 
activity during incubation at 37°C with 4 X 10 -3 M of IV: 
a) GAPDH (10 mg/ml); b) ADHy (5 mg/ml); c) myokinase 
(0.1 mg/ml); c)pyruvate kinase (6 mg/ml). Abs.: time in min. 
Ord.: % Activity. 
otide dependent enzymes attacking the phosphate 
binding site. 
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